Patents by Inventor Qinguan CAI

Qinguan CAI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IRAK4 inhibitor and use thereof
    Patent number: 10562902
    Abstract: Disclosed are a compound related to inhibiting the activity of an IRAK4 kinase, a pharmaceutical composition thereof, a use thereof in preparing drugs, a method in which same is used for inhibiting the activity of the IRAK4 kinase and a method in which same is used for treating and/or preventing IRAK4 kinase mediated diseases or conditions in mammals (especially humans). The compound has a structural formula I.
    Type: Grant
    Filed: August 12, 2016
    Date of Patent: February 18, 2020
    Assignee: Beijing Hanmi Pharmaceutical Co., Ltd.
    Inventors: Jiangcheng Xu, Qinguan Cai, Mi Young Cha, Maengsup Kim
  • IRAK4 INHIBITOR AND USE THEREOF
    Publication number: 20180244677
    Abstract: Disclosed are a compound related to inhibiting the activity of an IRAK4 kinase, a pharmaceutical composition thereof, a use thereof in preparing drugs, a method in which same is used for inhibiting the activity of the IRAK4 kinase and a method in which same is used for treating and/or preventing IRAK4 kinase mediated diseases or conditions in mammals (especially humans). The compound has a structural formula I.
    Type: Application
    Filed: August 12, 2016
    Publication date: August 30, 2018
    Applicant: BEIJING HANMI PHARMACEUTICAL CO., LTD.
    Inventors: Jiangcheng XU, Qinguan CAI, Mi Young CHA, Maengsup KIM